WC

William Canestaro

Healthcare and Biotech Investor | Advisor | Executive | Board Member

Seattle, Washington

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Literature Reviews
Decision Modeling
TreeAge
Microsoft Office
Written & Oral Presentation Skills
C-Level Presentations
Stata
Market Research
Business Development
Competitive Analysis
Biostatistics
Epidemiology
Outcomes Research
Health Services Research
Clinical Study Design
Biotechnology
Clinical Research
Clinical Trials
Data Analysis
Statistics

Education

Lists including William

AH
AL
AS
AD

Based in Seattle

494 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

SEngine Precision Medicine

Series A

Total Funding: $10M

Work Experience

PS
Pioneer Square Labs

2024

  • Health and Life Sciences Lead

    2024

PV
Pack Ventures

2024

  • Venture Partner

    2024

If
Institute for Protein Design, University of Washington

2024

  • Translational Advisor

    2024

GM
German Marshall Fund of the United States

2022

  • Marshall Memorial Fellow

    2022

TA
The Aspen Institute

2022

  • Better Arguments Ambassador

    2022

SO
School Of Pharmacy University Of Washington

2018

  • Member, Corporate Advisory Board

    2018

  • Affiliate Faculty

    2018

  • Advisor to WRF Health Economic and Outcomes Research Fellowship

    2018 - 2024

    The WRF-HEOR Fellowship aims to connect qualified researchers to meaningful health economic challenges facing Washington State life science companies. Health economics and outcomes research (HEOR) is increasingly being used at earlier stages of product development for healthcare and life sciences to inform decision making. While this expertise is commonly available at larger companies it may be unaffordable to smaller companies that have arguably the greatest need for that kind of service. The WRF-HEOR Fellowship would aim to address this gap by providing high-quality health economic and outcomes research services to WRF mission-related companies coming from qualified institutions in Washington state while also providing a valuable training activity for graduate students at Washington state research institutions.

  • Teaching Faculty for Systematic Reviews and Meta-Analyses

    2020 - 2023

    Designed and taught PHARM 540: Systematic Reviews and Meta-Analyses in the UW School of Pharmacy.

Uo
University of Washington - Michael G. Foster School of Business

2018

  • Teaching Faculty-Health Innovation Practicum

    2018

    This course is designed to give students an overview of the challenges that are necessary for any young business in healthcare or life sciences to consider. By the end of the course, students should expect to have an awareness of the system of regulation of health technologies, the process of development for health technologies, and the economics of healthcare. https://foster.uw.edu/centers/buerk-ctr-entrepreneurship/entrepreneurship-competitions/uw-health-innovation-challenge/

WR
Washington Research Foundation

2016 - 2025

  • Advisor

    2024 - 2025

  • Managing Director

    2018 - 2024

  • Manager, Strategic Investments

    2016 - 2018

  • Consultant

    2016 - 2016

PG
Phase Genomics

2023 - 2024

  • Member Board of Directors

    2023 - 2024

AB
Abacus Bioscience Inc

2023 - 2024

  • Member Board of Directors

    2023 - 2024